Polar Capital Holdings PLC Agios Pharmaceuticals, Inc. Transaction History
Polar Capital Holdings PLC
- $16.3 Billion
- Q4 2024
A detailed history of Polar Capital Holdings PLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 627,036 shares of AGIO stock, worth $22.1 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
627,036
Previous 1,002,036
37.42%
Holding current value
$22.1 Million
Previous $44.5 Million
53.72%
% of portfolio
0.13%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$200 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$198 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$171 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$124 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$85.4 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.93B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...